Medipharm Labs Corp T.LABS

Epidiolex generic approved by Jazz…our partner?

[alleyesonme]

On the Y/E CC Keith said "they are preparing for epidiolex generic in the U.S....this is very intriguing because.....https://www.greenmarketreport.com/judge-not-swayed-in-patent-battle-over-epidiolex-patents/.   According to Jazz’s filings, in October 2023, it settled with Padagis US LLC and granted Padagis a license to manufacture, market, and sell its generic version of Epidiolex on a date that depends on the occurrence of certain other events. However, the settlement wasn’t with the remaining litigants.

[mdjbrown]

alley, it would appear some of these defendants were hoping for a favorable decision based on a procedural technicality based on GWs original patent fillings. It worked for Avadel during their patent challenge against Jazz, but the courts in this action do not share the same thoughts. I am hopeful whoever Medipharms global partner challenging the validity of GWs Epidiolex patent has a bit more

[alleyesonme]

Mdj... According to Jazz’s filings, in October 2023, it settled with Padagis US LLC and granted Padagis a license to manufacture, market, and sell its generic version of Epidiolex on a date that depends on the occurrence of certain other events. However, the settlement wasn’t with the remaining litigants.

[mdjbrown]

alleysome, I get the impression this lawsuit is not concluded or settled in whole, as Jazz is the Plaintiff in this action. If in fact all of these ANDA filers were hanging their hats on something as weak as misrepresenting the number of employees Jazz had, that would be a colossal waste of both time and money.  Jazz settling with Padagis may have been a mutual legal way of Padagis stepping

[alleyesonme]

Mdj...for Keith to say they are preparing for epidiolex launch in the U.S and then to learn outta 14 pharmaceutical corps pagadis was granted manufacturing, marketing, approval by JAZZ for epidiolex generic tells me this is our partner...terms like the occurrence of other events will still be unknown but I feel strongly pagadis is our partner...supporting a Corp in a generic venture could be

[mdjbrown]

alleysome, that would be very interesting as US based Altaris owns Padagis, and they are certainly no strangers to the pharma sector. They have acquired several pharmaco's and are worth billions.. https://altariscap.com/ Padagis is an Isreal based outfit well known for early entry into pharma generics, which would fit. Would be nice to have some sort of update from Medipharm.